Home
Font Size:
1
2
3
Send to a Friend
Company
Mission
History
About Us
Awards
Contact
Driving Directions
Technology
Product Pipeline
MORAb-004
Farletuzumab
MORAb-009
Preclinical Pipeline
Clinical Trials
Farletuzumab
MORAb-004
MORAb-009
Partnerships
Research Alliances
News & Events
2010 News
2009 News Archive
2008 News Archive
2007 News Archive
2006 News Archive
2005 News Archive
2004 News Archive
2003 News Archive
2002 News Archive
2001 News Archive
Events
Careers
Current Job Openings
Our Work Environment
Benefits
Farletuzumab
MORAb-004
MORAb-009
MORAb-004
"A Study of MORAb-004 in Patients with Solid Tumors"
This Phase I trial is currently recruiting previously treated patients with advanced solid tumors to determine the safety, tolerability and pharmacokinetics of this new antibody.
Click here
for additional information about this trial.